株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

世界の免疫レパートリーシーケンシング市場の分析

Global Market Study on Immune Repertoire Sequencing: Research Center End Use Segment to Hold Significant Revenue Share Through 2026 Owing to Increased Focus on Cancer Immunotherapy Research

発行 Persistence Market Research 商品コード 739277
出版日 ページ情報 英文 219 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.81円で換算しております。
Back to Top
世界の免疫レパートリーシーケンシング市場の分析 Global Market Study on Immune Repertoire Sequencing: Research Center End Use Segment to Hold Significant Revenue Share Through 2026 Owing to Increased Focus on Cancer Immunotherapy Research
出版日: 2018年10月08日 ページ情報: 英文 219 Pages
概要

免疫レパートリーシーケンシングの世界市場は、2018年から2028年にかけて7.3%のCAGRで推移することが予測されています。シーケンシングプラットフォームの価格の下落や、遺伝子シーケンシングを含むバイオメディカル分野における新技術の融合などによって、特にアジア太平洋地域で免疫レパートリーシーケンシング市場の大きな成長が見込まれています。

当レポートでは、世界の免疫レパートリーシーケンシング市場を調査し、市場の概要、コンポーネント・用途・エンドユーザー・地域別の市場規模の推移と予測、市場動向、市場の成長要因および阻害要因の分析、市場機会、市場シェア、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 イントロダクション

  • 市場の定義
  • 市場の分類

第3章 市場機会の分析

  • マクロ経済要因
  • 市場機会の分析

第4章 市場の背景

  • 市場力学
    • 成長要因
    • 阻害要因
    • 市場機会
    • 市場動向

第5章 世界経済の見通し

  • 国内総生産:地域・国別
  • 医療市場の見通し

第6章 主な内容

  • 製品マッピング
  • 主な開発動向
  • 平均価格の分析:地域別

第7章 北米の免疫レパートリーシーケンシング市場

  • イントロダクション
  • 市場動向:国別(実績値・予測値)
    • 米国
    • カナダ
  • 市場動向:コンポーネント別(実績値・予測値)
    • アッセイキット
    • ソフトウェア・サービス
  • 市場動向:用途別(実績値・予測値)
    • バイオマーカー探索
    • 感染症
    • ワクチン開発
    • がん免疫療法
    • 自己免疫疾患
    • 移植拒絶反応・寛容
  • 市場動向:エンドユーザー別(実績値・予測値)
    • 学術機関
    • 研究機関
  • 市場魅力分析:セグメント別
  • 成長要因と阻害要因:影響分析

第8章 ラテンアメリカの免疫レパートリーシーケンシング市場

  • イントロダクション
  • 重要な規制
  • 市場力学
    • 成長要因
    • 阻害要因
    • 市場動向
  • 市場動向:国別(実績値・予測値)
    • ブラジル
    • メキシコ
    • その他
  • 市場動向:セグメント別(実績値・予測値)
  • 市場魅力分析:セグメント別
  • 成長要因と阻害要因:影響分析

第9章 欧州の免疫レパートリーシーケンシング市場

  • イントロダクション
  • 重要な規制
  • 市場力学
    • 成長要因
    • 阻害要因
    • 市場動向
  • 市場動向:国別(実績値・予測値)
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • ポーランド
    • ロシア
    • その他
  • 市場動向:セグメント別(実績値・予測値)
  • 市場魅力分析:セグメント別
  • 成長要因と阻害要因:影響分析

第10章 アジア太平洋地域の免疫レパートリーシーケンシング市場

  • イントロダクション
  • 重要な規制
  • 市場力学
    • 成長要因
    • 阻害要因
    • 市場動向
  • 市場動向:国別(実績値・予測値)
    • 中国
    • インド
    • 日本
    • オーストラリア・ニュージーランド
    • その他
  • 市場動向:セグメント別(実績値・予測値)
  • 市場魅力分析:セグメント別
  • 成長要因と阻害要因:影響分析

第11章 中東・アフリカの免疫レパートリーシーケンシング市場

  • イントロダクション
  • 重要な規制
  • 市場力学
    • 成長要因
    • 阻害要因
    • 市場動向
  • 市場動向:国別(実績値・予測値)
    • 湾岸協力会議(GCC)
    • 南アフリカ
    • その他
  • 市場動向:セグメント別(実績値・予測値)
  • 市場魅力分析:セグメント別
  • 成長要因と阻害要因:影響分析

第12章 予測要因:関連性と影響

第13章 市場構造の分析

  • 市場構造:企業別
  • コンペティションダッシュボード
  • 市場シェア分析

第14章 企業プロファイル

  • 企業プロファイル
    • Illumina, Inc.
    • Pacific Biosciences of California, Inc
    • Agilent Technologies, Inc
    • Oxford Nanopore Technologies, Ltd
    • QIAGEN N.V.
    • Thermo Fisher Scientific
    • F. Hoffmann-La Roche Ltd
    • BGI
    • タカラバイオ

第15章 世界の免疫レパートリーシーケンシング市場:地域別

  • イントロダクション
    • ベーシスポイントシェア(BPS)分析:地域別
    • 前年比成長率の見通し:地域別
  • 市場規模の分析:地域別(実績値・予測値)
    • 北米
    • ラテンアメリカ
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ
  • 市場魅力分析:地域別

第16章 世界の免疫レパートリーシーケンシング市場:コンポーネント別

  • イントロダクション
    • ベーシスポイントシェア(BPS)分析:コンポーネント別
    • 前年比成長率の見通し:コンポーネント別
  • 市場規模:コンポーネント別(実績値・予測値)
    • アッセイキット
    • ソフトウェア・サービス
  • 市場規模の分析:コンポーネント別
  • 市場魅力分析:コンポーネント別

第17章 世界の免疫レパートリーシーケンシング市場:用途別

  • イントロダクション
    • ベーシスポイントシェア(BPS)分析:用途別
    • 前年比成長率の見通し:用途別
  • 市場規模の分析:用途別(実績値・予測値)
    • バイオマーカー探索
    • 感染症
    • ワクチン開発
    • がん免疫療法
    • 自己免疫疾患
    • 移植拒絶反応・寛容
    • その他
  • 市場魅力分析:用途別

第18章 世界の免疫レパートリーシーケンシング市場:エンドユーザー別

  • イントロダクション
    • ベーシスポイントシェア(BPS)分析:エンドユーザー別
    • 前年比成長率の見通し:エンドユーザー別
  • 市場規模:エンドユーザー別(実績値・予測値)
    • 学術機関
    • 研究機関
  • 市場魅力分析:エンドユーザー別

第19章 世界の免疫レパートリーシーケンシング市場

  • 市場規模と成長率

第20章 頭字語

第21章 調査方法

図表

List of Tables

  • Table 01: Expenditure on Health, (% of GDP), by Country, 2016 - 2021
  • Table 02: Expenditure on Health, (% of GDP), by Country, 2016 - 2021
  • Table 03: Assay Kits Product Mapping
  • Table 04: Assay Kits Product Mapping
  • Table 05: Software Services Product Mapping
  • Table 06: Software Services Product Mapping
  • Table 07: Software Services Product Mapping
  • Table 08: Software & Services Product Mapping
  • Table 09: Software & Services Product Mapping
  • Table 10: Key Developments
  • Table 11: Key Developments
  • Table 12 : North America Immune Repertoire Sequencing Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
  • Table 13 : North America Immune Repertoire Sequencing Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Component
  • Table 14 : North America Immune Repertoire Sequencing Market Size Analysis 2013-2017 and Forecast 2018-2026, By Application
  • Table 15 : North America Immune Repertoire Sequencing Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By End User
  • Table 16 : Latin America Immune Repertoire Sequencing Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
  • Table 17 : Latin America Immune Repertoire Sequencing Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Component
  • Table 18 : Latin America Immune Repertoire Sequencing Market Size Analysis 2013-2017 and Forecast 2018-2026, By Application
  • Table 19 : Latin America Immune Repertoire Sequencing Market Size Analysis 2013-2017 and Forecast 2018-2026, By End User
  • Table 20 : Europe Immune Repertoire Sequencing Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
  • Table 21 : Europe Immune Repertoire Sequencing Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Component
  • Table 22 : Europe Immune Repertoire Sequencing Market Size Analysis 2013-2017 and Forecast 2018-2026, By Application
  • Table 23 : Europe Immune Repertoire Sequencing Market Size Analysis 2013-2017 and Forecast 2018-2026, By End User
  • Table 24 : Asia Pacific Immune Repertoire Sequencing Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
  • Table 25 : Asia Pacific Immune Repertoire Sequencing Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Component
  • Table 26 : Asia Pacific Immune Repertoire Sequencing Market Size Analysis 2013-2017 and Forecast 2018-2026, By Application
  • Table 27 : Asia Pacific Immune Repertoire Sequencing Market Size Analysis 2013-2017 and Forecast 2018-2026, By End User
  • Table 28 : Middle East & Africa Immune Repertoire Sequencing Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
  • Table 29 : Middle East & Africa Immune Repertoire Sequencing Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Component
  • Table 30 : Middle East & Africa Immune Repertoire Sequencing Market Size Analysis 2013-2017 and Forecast 2018-2026, By Application
  • Table 31 : Middle East & Africa Immune Repertoire Sequencing Market Size Analysis 2013-2017 and Forecast 2018-2026, By End User
  • Table 32 : Global Immune Repertoire Sequencing Market Size (US$ Mn) 2013-2017 and Forecast 2018-2026 By Region
  • Table 33 : Global Market Size (US$ Mn) 2013-2017 and Forecast 2018-2026 By Component
  • Table 34 : Global Market Size (US$ Mn) 2013-2017 and Forecast 2018-2026 By Application
  • Table 35 : Global Market Size (US$ Mn) 2013-2017 and Forecast 2018-2026 By End User

List of Figures

  • Figure 01 : Global Healthcare Expenditure in US$ Tn (2013-2020)
  • Figure 02: Regional Average Pricing Analysis (US$) of Assay Kits (2017)
  • Figure 03: Regional Average Pricing Analysis (US$) of Assay Kits s (2026)
  • Figure 04: Regional Average Pricing Analysis (US$) Software & Services (2017)
  • Figure 05: Regional Average Pricing Analysis (US$) Software & Services (2026)
  • Figure 6 : North America Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 7 : North America Immune Repertoire Sequencing Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 8 : U.S. Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 9 : U.S. Immune Repertoire Sequencing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 10 : Canada Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 11 : Canada Immune Repertoire Sequencing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 12 : Assay Kits Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 13 : Assay Kits Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 14 : Software Service Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 15 : Software Service Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 16 : North America Medical immune repertoire sequencing Detectors Market Attractiveness Analysis, By Component
  • Figure 17 : North America Medical immune repertoire sequencing Detectors Market Attractiveness Analysis, By Application
  • Figure 18 : North America Medical immune repertoire sequencing Detectors Market Attractiveness Analysis, By End User
  • Figure 19 : North America Medical immune repertoire sequencing Detectors Market Attractiveness Analysis, By Country
  • Figure 20 : Latin America Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 21 : Latin America Immune Repertoire Sequencing Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 22 : Brazil Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 23 : Brazil Immune Repertoire Sequencing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 24 : Mexico Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 25: Mexico Immune Repertoire Sequencing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 26 : Rest of Latin America Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 27 : Rest of Latin America Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 28 :Latin America Medical immune repertoire sequencing Detectors Market Attractiveness Analysis, By Component
  • Figure 29 : Latin America Medical immune repertoire sequencing Detectors Market Attractiveness Analysis, By Application
  • Figure 30 : Latin America Medical immune repertoire sequencing Detectors Market Attractiveness Analysis, By End User
  • Figure 31 : Latin America Medical immune repertoire sequencing Detectors Market Attractiveness Analysis, By Country
  • Figure 32 : Europe Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 33 : Europe Immune Repertoire Sequencing Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 34 : Germany Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 35 : Germany Immune Repertoire Sequencing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 36 : U.K Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 37 : U.K. Immune Repertoire Sequencing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 38 : France Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 39 : France Immune Repertoire Sequencing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 40 : Spain Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 41 : Spain Immune Repertoire Sequencing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 42 : Italy Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 43 : Italy Immune Repertoire Sequencing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 44 : Russia Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 45 : Russia Repertoire Sequencing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 46 : Poland Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 47 : Poland Immune Repertoire Sequencing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 48 : Rest of Europe Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 49 : Rest of Europe Repertoire Sequencing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 50 : Europe immune repertoire sequencing Detectors Market Attractiveness Analysis, By Component
  • Figure 51 : Europe immune repertoire sequencing Detectors Market Attractiveness Analysis, By Application
  • Figure 52 : Europe immune repertoire sequencing Detectors Market Attractiveness Analysis, By End User
  • Figure 53 : Europe immune repertoire sequencing Detectors Market Attractiveness Analysis, By Country
  • Figure 54 : Asia Pacific Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 55 : Asia Pacific Immune Repertoire Sequencing Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 56 : India Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 57 : India Immune Repertoire Sequencing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 58 : Aus & NZ Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 59 : Aus & NZ . Immune Repertoire Sequencing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 60 : China Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 61 : China Immune Repertoire Sequencing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 62 : Japan Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 63 : Japan Immune Repertoire Sequencing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 64 : Rest of Asia Pacific Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 65 : Rest of Asia Pacific Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 66 : Asia Pacific immune repertoire sequencing Detectors Market Attractiveness Analysis, By Component
  • Figure 67 : Asia Pacific immune repertoire sequencing Detectors Market Attractiveness Analysis, By Application
  • Figure 68 : Asia Pacific repertoire sequencing Detectors Market Attractiveness Analysis, By End User
  • Figure 69 : Asia Pacific repertoire sequencing Detectors Market Attractiveness Analysis, By Country
  • Figure 70 : MEA Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 71 : MEA Immune Repertoire Sequencing Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 72 : GCC Countries Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 73 : GCC Countries Immune Repertoire Sequencing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 74 : South Africa Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 75 : South Africa Immune Repertoire Sequencing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 76 : Rest of Middle East & Africa Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 77 : Rest of Middle East & Africa Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 78 : Middle East & Africa immune repertoire sequencing Detectors Market Attractiveness Analysis, By Component
  • Figure 79 : Middle East & Africa immune repertoire sequencing Detectors Market Attractiveness Analysis, By Application
  • Figure 80 : Middle East & Africa immune repertoire sequencing Detectors Market Attractiveness Analysis, By End User
  • Figure 81 : Middle East & Africa immune repertoire sequencing Detectors Market Attractiveness Analysis, By Country
  • Figure 82 : Global Immune Repertoire Sequencing Market Share Analysis (%) By Region, 2018 & 2026
  • Figure 83 : Global Immune Repertoire Sequencing Market Y-o-Y Growth (%) By Region, 2017-2026
  • Figure 84 : Global Immune Repertoire Sequencing Market Attractiveness Analysis By Region, 2018-2026
  • Figure 85 : Global Market Share Analysis (%) By Component, 2018 & 2026
  • Figure 86 : Global Market Y-o-Y Growth (%) By Component, 2017-2026
  • Figure 87 : Global Market Attractiveness Analysis Component, 2018-2026
  • Figure 88 : Global Market Share Analysis (%) By Application , 2018 & 2026
  • Figure 89 : Global Market Y-o-Y Growth (%) By Application, 2017-2026
  • Figure 90 : Global Market Attractiveness Analysis By Application, 2018-2026
  • Figure 91 : Global Market Share Analysis (%) By End User , 2018 & 2026
  • Figure 92 : Global Market Y-o-Y Growth (%) By End User, 2017-2026
  • Figure 93 : Global Market Attractiveness Analysis By End User, 2018-2026
  • Figure 94 : Global Immune Repertoire Sequencing Market Value Analysis and Forecast, 2017-2026 (US$ Mn)
  • Figure 95 : Global Immune Repertoire Sequencing Market Absolute $ Opportunity (US$ Mn), 2017-2026
目次

Persistence Market Research (PMR) offers an eight year forecast on the global immune repertoire sequencing market. The primary objective of the report is to offer updates and information related to the opportunities in the immune repertoire sequencing market.

Report Description

In terms of revenue, the global immune repertoire sequencing market is expected to register a CAGR of 7.3% during the forecast period, 2018-2028. The primary objective of the report is to offer insights on the market dynamics that can influence the growth of the global immune repertoire sequencing market over the forecast period. Insights on the key trends, drivers, restraints, value forecasts and opportunities for the companies operating in the global immune repertoire sequencing market are presented in the report.

The global market for immune repertoire sequencing is expected to witness high growth in terms of value in Asian countries due to substantial price drop in sequencing platforms and integration of new technologies in biomedical research including advancement in genome sequencing. In addition, increasing international collaboration in immune repertoire sequencing projects by other developing nations is also expected to drive the growth of the immune repertoire sequencing market.

The report includes immune repertoire sequencing component types such as assay kits, software (including software integrated system platforms) and services. However, the report does not include revenue generated by the instruments or devices (running without integrated software) and accessories incurred in various academic institutions and research centres. Revenues of third-party service vendors or representatives of primary service providers are excluded in the report. Besides, the currency fluctuations and inflation are not considered while calculating the revenue of the global immune repertoire sequencing market.

To understand and assess the opportunities in this market, the report offers the market forecast on the basis of segment type classified into the component type, application, end users and regions. The report provides analysis of the global immune repertoire sequencing market in terms of market value (US$ Mn).

By component type, the global immune repertoire sequencing market is segmented into:

  • Assay Kits
  • TCR Kits
  • BCR Kits
  • Software & Services
  • Analytical Software
  • Sequencing Services
  • Data Analysis Services

The report begins with the definition of immune repertoire sequencing, followed by definitions of different product types. The market dynamics section includes PMR's analysis on the key trends, drivers, restraints, opportunities, macro-economic factors and key market strategies influencing the growth of the global immune repertoire sequencing market.

The report analyses the immune repertoire sequencing market on the basis of application type and end users and presents forecast in terms of value for the next 10 years. On the basis of application, the global immune repertoire sequencing market is segmented into:

  • Biomarker Discovery
  • Infectious Diseases
  • Vaccine Development and efficacy
  • Cancer Immunotherapy
  • Autoimmune Disease
  • Transplant Rejection and Tolerance
  • Others

On the basis of the end users, the global immune repertoire sequencing market is segmented into:

  • Academic Institutes
  • Research Centers Diagnostic laboratories

Next, the report analyses the market on the basis of regions and presents forecast in terms of value for the next 10 years. On the basis of region, the global immune repertoire sequencing market is segmented into:

  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Poland
  • Russia
  • Rest of Eastern Europe
  • Asia Pacific
  • India
  • China
  • Japan
  • Australia & New Zealand
  • Rest of Asia- Pacific
  • Middle East & Africa (MEA)
  • GCC countries
  • South Africa
  • Rest of Middle East and Africa

In addition, we have considered the Year-on-Year (Y-o-Y) growth to understand the predictability of the market and identify growth opportunities for companies operating in the global immune repertoire sequencing market.

Another key feature of this report is the analysis of the key segments in immune repertoire sequencing market in terms of absolute dollar opportunity. This is usually overlooked while forecasting the market. However, absolute dollar opportunity is critical for assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales and delivery perspective for services offered in the global immune repertoire sequencing market. To understand the key segments in terms of their growth and performance in the global immune repertoire sequencing market, PMR has developed a market attractiveness index. The resulting index will help identify the existing opportunities in the global immune repertoire sequencing market.

In the final section of the report, the 'competitive landscape' has been included to provide a dashboard view of the key companies operating in the global immune repertoire sequencing market. This section is primarily designed to provide clients with an objective and detailed comparative assessment of the key provider's specific to a market segment in the global immune repertoire sequencing market. However, this section also includes market strategies and SWOT analysis of the key players operating in the global immune repertoire sequencing market.

Detailed profiles of the assay kit manufacturers, software and service providers of immune repertoire sequencing are also included in the scope of the report to evaluate their long- and short-term strategies. Examples of some of the key players operating in the global immune repertoire sequencing market are Illumina, Takara Bio Inc, BGI, Thermo Fischer Scientific, and F. Hoffmann-La Roche Ltd, among others.

Table of Contents

1. Executive Summary

  • 1.1. Market Overview
  • 1.2. Market Analysis
  • 1.3. PMR Analysis and Recommendations
  • 1.4. Wheel of Fortune

2. Market Introduction

  • 2.1. Market Definition
  • 2.2. Market Taxonomy

3. Immune Repertoire Sequencing Market Opportunity Analysis

  • 3.1. Macro-Economic Factors
  • 3.2. Opportunity Analysis

4. Market Background

  • 4.1. Market Dynamics
    • 4.1.1. Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunity
    • 4.1.4. Trends

5. Global Economic Outlook

  • 5.1. Gross Domestic Product by Region & Country, 2006 - 2021
  • 5.2. Global Healthcare Market Outlook

6. Key Inclusions

  • 6.1. Product Mapping
  • 6.2. Key Developments
  • 6.3. Regional Average Pricing Analysis (2017)

7. North America Immune Repertoire Sequencing Market Analysis 2013-2017 and Forecast 2018-2026

  • 7.1. Introduction
  • 7.2. Historical Market Value (US$ Mn) Trend Analysis By Country, 2013-2017
    • 7.2.1. U.S.
    • 7.2.2. Canada
  • 7.3. Market Value (US$ Mn) Forecast By Country, 2018-2026
  • 7.4. Historical Market Value (US$ Mn) and By Component, 2012-2016
    • 7.4.1. Assay Kits
      • 7.4.1.1. TCR Kits
      • 7.4.1.2. BCR Kits
    • 7.4.2. Software & Services
      • 7.4.2.1. Analytical Software
      • 7.4.2.2. Sequencing Services
      • 7.4.2.3. Data Analysis Services
  • 7.5. Market Value (US$ Mn) and Forecast By Component, 2018-2026
  • 7.6. Historical Market Value(US$ Mn) By Application, 2012-2016
    • 7.6.1. Biomarker Discovery
    • 7.6.2. Infectious Diseases
    • 7.6.3. Vaccine Development and efficacy
    • 7.6.4. Cancer Immunotherapy
    • 7.6.5. Autoimmune Disease
    • 7.6.6. Transplant Rejection and Tolerance
    • 7.6.7. Others
  • 7.7. Market Value (US$ Mn) Forecast By Application, 2018-2026
  • 7.8. Historical Market Value (US$ Mn) By End user, 2012-2016
    • 7.8.1. Academic Institutes
    • 7.8.2. Research Centers
  • 7.9. Market Value (US$ Mn) Forecast By End user,2018-2026
  • 7.10. Market Attractiveness Analysis
    • 7.10.1. By Country
    • 7.10.2. By Component
    • 7.10.3. By Application
    • 7.10.4. By End user
  • 7.11. Drivers and Restraints: Impact Analysis

8. Latin America Immune Repertoire Sequencing Market Analysis 2013-2017 and Forecast 2018-2026

  • 8.1. Introduction
  • 8.2. Key Regulations
  • 8.3. Regional Market Dynamics
    • 8.3.1. Drivers
    • 8.3.2. Restraints
    • 8.3.3. Trends
  • 8.4. Historical Market Size (US$ Mn) and By Country, 2012-2016
    • 8.4.1. Brazil
    • 8.4.2. Mexico
    • 8.4.3. Rest of Latin America
  • 8.5. Market Size (US$ Mn) and Forecast By Country, 2018-2026
  • 8.6. Historical Market Value (US$ Mn) and By Component, 2012-2016
    • 8.6.1. Assay Kits
      • 8.6.1.1. TCR Kits
      • 8.6.1.2. BCR Kits
    • 8.6.2. Software & Services
      • 8.6.2.1. Analytical Software
      • 8.6.2.2. Sequencing Services
      • 8.6.2.3. Data Analysis Services
  • 8.7. Market Value (US$ Mn) and Forecast By Component, 2018-2026
  • 8.8. Historical Market Value (US$ Mn) By Application, 2012-2016
    • 8.8.1. Biomarker Discovery
    • 8.8.2. Infectious Diseases
    • 8.8.3. Vaccine Development and efficacy
    • 8.8.4. Cancer Immunotherapy
    • 8.8.5. Autoimmune Disease
    • 8.8.6. Transplant Rejection and Tolerance
    • 8.8.7. Others
  • 8.9. Market Value (US$ Mn) Forecast By Application, 2018-2026
  • 8.10. Historical Market Value (US$ Mn) By End user, 2012-2016
    • 8.10.1. Academic Institutes
    • 8.10.2. Research Centers
  • 8.11. Market Value (US$ Mn) Forecast By End user, 2018-2026
  • 8.12. Market Attractiveness Analysis
    • 8.12.1. By Country
    • 8.12.2. By Component
    • 8.12.3. By Application
    • 8.12.4. By End user
  • 8.13. Drivers and Restraints: Impact Analysis

9. Europe Immune Repertoire Sequencing Market Analysis 2013-2017 and Forecast 2018-2026

  • 9.1. Introduction
  • 9.2. Key Regulations
  • 9.3. Regional Market Dynamics
    • 9.3.1. Drivers
    • 9.3.2. Restraints
    • 9.3.3. Trends
  • 9.4. Historical Market Size (US$ Mn) and By Country, 2012-2016
    • 9.4.1. Germany
    • 9.4.2. U.K.
    • 9.4.3. France
    • 9.4.4. Italy
    • 9.4.5. Spain
    • 9.4.6. Poland
    • 9.4.7. Russia
    • 9.4.8. Rest of Europe
  • 9.5. Market Size (US$ Mn) and Forecast By Country, 2018-2026
  • 9.6. Historical Market Value (US$ Mn) and By Component, 2012-2016
    • 9.6.1. Assay Kits
      • 9.6.1.1. TCR Kits
      • 9.6.1.2. BCR Kits
    • 9.6.2. Software & Services
      • 9.6.2.1. Analytical Software
      • 9.6.2.2. Sequencing Services
      • 9.6.2.3. Data Analysis Services
  • 9.7. Market Value (US$ Mn) and Forecast By Component, 2018-2026
  • 9.8. Historical Market Value(US$ Mn) By Application, 2012-2016
    • 9.8.1. Biomarker Discovery
    • 9.8.2. Infectious Diseases
    • 9.8.3. Vaccine Development and efficacy
    • 9.8.4. Cancer Immunotherapy
    • 9.8.5. Autoimmune Disease
    • 9.8.6. Transplant Rejection and Tolerance
    • 9.8.7. Others
  • 9.9. Market Value (US$ Mn) Forecast By Application, 2018-2026
  • 9.10. Historical Market Value (US$ Mn) By End user, 2012-2016
    • 9.10.1. Academic Institutes
    • 9.10.2. Research Centers
  • 9.11. Market Value (US$ Mn) Forecast By End user, 2018-2026
  • 9.12. Market Attractiveness Analysis
    • 9.12.1. By Country
    • 9.12.2. By Component
    • 9.12.3. By Application
    • 9.12.4. By End user
  • 9.13. Drivers and Restraints: Impact Analysis

10. Asia Pacific (APAC) Immune Repertoire Sequencing Market Analysis 2013-2017 and Forecast 2018-2026

  • 10.1. Introduction
  • 10.2. Key Regulations
  • 10.3. Regional Market Dynamics
    • 10.3.1. Drivers
    • 10.3.2. Restraints
    • 10.3.3. Trends
  • 10.4. Historical Market Size (US$ Mn) and By Country, 2012-2016
    • 10.4.1. China
    • 10.4.2. India
    • 10.4.3. Japan
    • 10.4.4. Australia and New Zealand
    • 10.4.5. Rest of APAC
  • 10.5. Market Size (US$ Mn) and Forecast By Country, 2018-2026
  • 10.6. Historical Market Value (US$ Mn) and By Component, 2012-2016
    • 10.6.1. Assay Kits
      • 10.6.1.1. TCR Kits
      • 10.6.1.2. BCR Kits
    • 10.6.2. Software & Services
      • 10.6.2.1. Analytical Software
      • 10.6.2.2. Sequencing Services
      • 10.6.2.3. Data Analysis Services
  • 10.7. Market Value (US$ Mn) and Forecast By Component, 2018-2026
  • 10.8. Historical Market Value (US$ Mn) By Application, 2012-2016
    • 10.8.1. Biomarker Discovery
    • 10.8.2. Infectious Diseases
    • 10.8.3. Vaccine Development and efficacy
    • 10.8.4. Cancer Immunotherapy
    • 10.8.5. Autoimmune Disease
    • 10.8.6. Transplant Rejection and Tolerance
    • 10.8.7. Others
  • 10.9. Market Value (US$ Mn) Forecast By Application, 2018-2026
  • 10.10. Historical Market Value (US$ Mn) By End user, 2012-2016
    • 10.10.1. Academic Institutes
    • 10.10.2. Research Centers
  • 10.11. Market Value (US$ Mn) Forecast By End user,2018-2026
  • 10.12. Market Attractiveness Analysis
    • 10.12.1. By Country
    • 10.12.2. By Component
    • 10.12.3. By Application
    • 10.12.4. By End user
  • 10.13. Drivers and Restraints: Impact Analysis

11. Middle East and Africa (MEA) Immune Repertoire Sequencing Market Analysis 2013-2017 and Forecast 2018-2026

  • 11.1. Introduction
  • 11.2. Key Regulations
  • 11.3. Regional Market Dynamics
    • 11.3.1. Drivers
    • 11.3.2. Restraints
    • 11.3.3. Trends
  • 11.4. Historical Market Size (US$ Mn) and By Country, 2012-2016
    • 11.4.1. GCC Countries
    • 11.4.2. South Africa
    • 11.4.3. Rest of MEA
  • 11.5. Market Size (US$ Mn) and Forecast By Country, 2018-2026
  • 11.6. Historical Market Value (US$ Mn) and By Component, 2012-2016
    • 11.6.1. Assay Kits
      • 11.6.1.1. TCR Kits
      • 11.6.1.2. BCR Kits
    • 11.6.2. Software & Services
      • 11.6.2.1. Analytical Software
      • 11.6.2.2. Sequencing Services
      • 11.6.2.3. Data Analysis Services
  • 11.7. Market Value (US$ Mn) and Forecast By Component, 2018-2026
  • 11.8. Historical Market Value(US$ Mn) By Application, 2012-2016
    • 11.8.1. Biomarker Discovery
    • 11.8.2. Infectious Diseases
    • 11.8.3. Vaccine Development and efficacy
    • 11.8.4. Cancer Immunotherapy
    • 11.8.5. Autoimmune Disease
    • 11.8.6. Transplant Rejection and Tolerance
    • 11.8.7. Others
  • 11.9. Market Value (US$ Mn) Forecast By Application, 2018-2026
  • 11.10. Historical Market Value (US$ Mn) By End user, 2012-2016
    • 11.10.1. Academic Institutes
    • 11.10.2. Research Centers
  • 11.11. Market Value (US$ Mn) Forecast By End user,2018-2026
  • 11.12. Market Attractiveness Analysis
    • 11.12.1. By Country
    • 11.12.2. By Component
    • 11.12.3. By Application
    • 11.12.4. By End user
  • 11.13. Drivers and Restraints: Impact Analysis

12. Forecast Factors: Relevance and Impact

13. Market Structure Analysis

  • 13.1. Market Structure by Tier Companies
  • 13.2. Competition Dashboard
  • 13.3. Market Share Analysis (2017) by Global level

14. Competition Profile

  • 14.1. Company Deep Dive
    • 14.1.1. Illumina, Inc.
      • 14.1.1.1. Overview
      • 14.1.1.2. Key Financials
      • 14.1.1.3. Product and Application Portfolio
      • 14.1.1.4. Key Developments
      • 14.1.1.5. Strategy
        • 14.1.1.5.1.1. Marketing Strategy
        • 14.1.1.5.1.2. Product Strategy
        • 14.1.1.5.1.3. Channel Strategy
    • 14.1.2. Pacific Biosciences of California, Inc
      • 14.1.2.1. Overview
      • 14.1.2.2. Key Financials
      • 14.1.2.3. Product and Application Portfolio
      • 14.1.2.4. Key Developments
      • 14.1.2.5. Strategy
        • 14.1.2.5.1.1. Marketing Strategy
        • 14.1.2.5.1.2. Product Strategy
        • 14.1.2.5.1.3. Channel Strategy
    • 14.1.3. Agilent Technologies, Inc
      • 14.1.3.1. Overview
      • 14.1.3.2. Key Financials
      • 14.1.3.3. Product and Application Portfolio
      • 14.1.3.4. Key Developments
      • 14.1.3.5. Strategy
        • 14.1.3.5.1.1. Marketing Strategy
        • 14.1.3.5.1.2. Product Strategy
        • 14.1.3.5.1.3. Channel Strategy
    • 14.1.4. Oxford Nanopore Technologies, Ltd
      • 14.1.4.1. Overview
      • 14.1.4.2. Product and Application Portfolio
      • 14.1.4.3. Key Developments
      • 14.1.4.4. Strategy
        • 14.1.4.4.1.1. Marketing Strategy
        • 14.1.4.4.1.2. Product Strategy
        • 14.1.4.4.1.3. Channel Strategy
    • 14.1.5. QIAGEN N.V.
      • 14.1.5.1. Overview
      • 14.1.5.2. Key Financials
      • 14.1.5.3. Product and Application Portfolio
      • 14.1.5.4. Key Developments
      • 14.1.5.5. Strategy
        • 14.1.5.5.1.1. Marketing Strategy
        • 14.1.5.5.1.2. Product Strategy
        • 14.1.5.5.1.3. Channel Strategy
    • 14.1.6. Thermo Fisher Scientific
      • 14.1.6.1. Overview
      • 14.1.6.2. Key Financials
      • 14.1.6.3. Product and Application Portfolio
      • 14.1.6.4. Key Developments
      • 14.1.6.5. Strategy
        • 14.1.6.5.1.1. Marketing Strategy
        • 14.1.6.5.1.2. Product Strategy
        • 14.1.6.5.1.3. Channel Strategy
    • 14.1.7. F. Hoffmann-La Roche Ltd
      • 14.1.7.1. Overview
      • 14.1.7.2. Key Financials
      • 14.1.7.3. Product and Application Portfolio
      • 14.1.7.4. Key Developments
      • 14.1.7.5. Strategy
        • 14.1.7.5.1.1. Marketing Strategy
        • 14.1.7.5.1.2. Product Strategy
        • 14.1.7.5.1.3. Channel Strategy
        • 14.1.7.5.1.4. Channel Strategy
    • 14.1.8. BGI
      • 14.1.8.1. Overview
      • 14.1.8.2. Product and Application Portfolio
      • 14.1.8.3. Key Developments
      • 14.1.8.4. Strategy
        • 14.1.8.4.1.1. Marketing Strategy
        • 14.1.8.4.1.2. Product Strategy
        • 14.1.8.4.1.3. Channel Strategy
        • 14.1.8.4.1.4. Channel Strategy
    • 14.1.9. Takara Bio, Inc
      • 14.1.9.1. Overview
      • 14.1.9.2. Key Financials
      • 14.1.9.3. Product and Application Portfolio
      • 14.1.9.4. Key Developments
      • 14.1.9.5. Strategy
        • 14.1.9.5.1.1. Marketing Strategy
        • 14.1.9.5.1.2. Product Strategy
        • 14.1.9.5.1.3. Channel Strategy
        • 14.1.9.5.1.4. Channel Strategy

15. Global Immune Repertoire Sequencing Market Analysis 2013-2017 and Forecast 2018-2026, By Region

  • 15.1. Introduction
    • 15.1.1. Basis Point Share (BPS) Analysis By Region
    • 15.1.2. Y-o-Y Growth Projections By Region
  • 15.2. Historical Market Value Analysis 2013-2017, By Region
    • 15.2.1. North America
    • 15.2.2. Latin America
    • 15.2.3. Europe
    • 15.2.4. Asia Pacific (APAC)
    • 15.2.5. Middle East and Africa (MEA)
  • 15.3. Market Value Analysis 2018-2026, By Region
    • 15.3.1. North America
    • 15.3.2. Latin America
    • 15.3.3. Europe
    • 15.3.4. Asia Pacific (APAC)
    • 15.3.5. Middle East and Africa (MEA)
  • 15.4. Market Attractiveness Analysis By Region

16. Global Immune Repertoire Sequencing Market Analysis 2013-2017 and Forecast 2018-2026, By Component

  • 16.1. Introduction
    • 16.1.1. Basis Point Share (BPS) Analysis By Component
    • 16.1.2. Y-o-Y Growth Projections By Component
  • 16.2. Historical Market Value Analysis 2013-2017, By Component
    • 16.2.1. Assay Kits
      • 16.2.1.1. TCR Kits
      • 16.2.1.2. BCR Kits
    • 16.2.2. Software & Services
      • 16.2.2.1. Analytical Software
      • 16.2.2.2. Sequencing Services
      • 16.2.2.3. Data Analysis Services
  • 16.3. Market Value Analysis 2017-2015, By Component
  • 16.4. Market Attractiveness Analysis By Component

17. Global Immune Repertoire Sequencing Market Analysis 2013-2017 and Forecast 2018-2026, By Applications

  • 17.1. Introduction
    • 17.1.1. Basis Point Share (BPS) Analysis By Applications
    • 17.1.2. Y-o-Y Growth Projections By Applications
  • 17.2. Historical Market Value Analysis 2013-2017, By Applications
    • 17.2.1. Biomarker Discovery
    • 17.2.2. Infectious Diseases
    • 17.2.3. Vaccine Development and efficacy
    • 17.2.4. Cancer Immunotherapy
    • 17.2.5. Autoimmune Disease
    • 17.2.6. Transplant Rejection and Tolerance
    • 17.2.7. Others
  • 17.3. Historical Market Value Analysis 2018-2026, By Applications
  • 17.4. Market Attractiveness Analysis By Applications

18. Global Immune Repertoire Sequencing Market Analysis 2013-2017 and Forecast 2018-2026, By End User

  • 18.1. Introduction
    • 18.1.1. Basis Point Share (BPS) Analysis By End User
    • 18.1.2. Y-o-Y Growth Projections By End User
  • 18.2. Historical Market Value Analysis 2013-2017, By End User
    • 18.2.1. Academic Institutes
    • 18.2.2. Research Centers
  • 18.3. Market Value Analysis 2018-2026, By End User
  • 18.4. Market Attractiveness Analysis By End User

19. Global Immune Repertoire Sequencing Market Analysis 2013-2017 and Forecast 2017-2026

  • 19.1. Market Size and Y-o-Y Growth
  • 19.2. Absolute $ Opportunity

20. Assumptions and Acronyms Used

21. Research Methodology

Back to Top